Exclusive: U.S. medical testing, cancer screenings plunge during coronavirus outbreak -data firm analysis [Reuters]
Phreesia, Inc. (PHR)
Last phreesia, inc. earnings: 4/22 04:09 pm
Check Earnings Report
Company Research
Source: Reuters
Exclusive: U.S. medical testing, cancer screenings plunge during coronavirus outbreak -data firm analysis (Reuters) - Routine medical tests critical for detecting and monitoring cancer and other conditions plummeted in the United States since mid-March, as the coronavirus spread and public officials urged residents to stay home, according to a new report by Komodo Health. Diagnostic panels and cancer screenings typically performed during annual physician visits fell by as much as 68% nationally, and by even more in coronavirus hotspots. These tests, office visits, surgeries and other medical care tied to them, are key sources of revenue for hospitals and healthcare systems that had to curb lucrative elective procedures to assure room for a crush of patients with COVID-19, the illness caused by the new coronavirus. Millions of patients postponed tests considered crucial for detecting early signs of disease, monitoring its progression and improving patient outcomes, according to Komodo,
Show less
Read more
Impact Snapshot
Event Time:
PHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PHR alerts
High impacting Phreesia, Inc. news events
Weekly update
A roundup of the hottest topics
PHR
News
- Revisiting Phreesia (PHR) Valuation After Upbeat Analyst Commentary and Earnings Expectations [Yahoo! Finance]Yahoo! Finance
- Phreesia's Megan Turco Named to MM+M 40 Under 40 [Yahoo! Finance]Yahoo! Finance
- Phreesia’s Megan Turco Named to MM+M 40 Under 40Business Wire
- Phreesia (NYSE:PHR) had its price target raised by analysts at DA Davidson from $33.00 to $35.00. They now have a "buy" rating on the stock.MarketBeat
- Phreesia (PHR) Earnings Expected to Grow: Should You Buy? [Yahoo! Finance]Yahoo! Finance
PHR
Earnings
- 9/4/25 - Beat
PHR
Sec Filings
- 11/13/25 - Form SCHEDULE
- 11/12/25 - Form 8-K
- 11/5/25 - Form SCHEDULE
- PHR's page on the SEC website